Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics

被引:0
|
作者
Daniëlle van Manen
Angélique B van ‘t Wout
Hanneke Schuitemaker
机构
[1] University of Amsterdam,Department of Experimental Immunology, Sanquin Research, Landsteiner Laboratory, and Center for Infectious Diseases and Immunity Amsterdam (CINIMA), Academic Medical Center
[2] Crucell Holland B.V.,undefined
来源
关键词
Genome-wide association studies; Single-nucleotide polymorphisms; Host genetics; HIV susceptibility; HIV pathogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
Susceptibility to HIV-1 and the clinical course after infection show a substantial heterogeneity between individuals. Part of this variability can be attributed to host genetic variation. Initial candidate gene studies have revealed interesting host factors that influence HIV infection, replication and pathogenesis. Recently, genome-wide association studies (GWAS) were utilized for unbiased searches at a genome-wide level to discover novel genetic factors and pathways involved in HIV-1 infection. This review gives an overview of findings from the GWAS performed on HIV infection, within different cohorts, with variable patient and phenotype selection. Furthermore, novel techniques and strategies in research that might contribute to the complete understanding of virus-host interactions and its role on the pathogenesis of HIV infection are discussed.
引用
收藏
相关论文
共 50 条
  • [1] Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics
    van Manen, Danielle
    Wout, Angelique B. van 't
    Schuitemaker, Hanneke
    RETROVIROLOGY, 2012, 9
  • [2] Genome-wide association studies in pharmacogenomics
    Daly, Ann K.
    NATURE REVIEWS GENETICS, 2010, 11 (04) : 241 - 246
  • [3] Genome-wide association studies in pharmacogenomics
    Ann K. Daly
    Nature Reviews Genetics, 2010, 11 : 241 - 246
  • [4] Genome-wide association studies in pharmacogenomics of antidepressants
    Lin, Eugene
    Lane, Hsien-Yuan
    PHARMACOGENOMICS, 2015, 16 (05) : 555 - 566
  • [5] Ask the Experts Pharmacogenomics and genome-wide association studies
    Bond, Theo
    Hakonarson, Hakon
    PHARMACOGENOMICS, 2013, 14 (04) : 365 - 368
  • [6] Genome-wide association studies in pharmacogenomics: successes and lessons
    Motsinger-Reif, Alison A.
    Jorgenson, Eric
    Relling, Mary V.
    Kroetz, Deanna L.
    Weinshilboum, Richard
    Cox, Nancy J.
    Roden, Dan M.
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (08): : 383 - 394
  • [7] Genome-wide association studies in pharmacogenomics: untapped potential for translation
    Idris Guessous
    Marta Gwinn
    Muin J Khoury
    Genome Medicine, 1
  • [8] Genome-wide association studies in pharmacogenomics: untapped potential for translation
    Guessous, Idris
    Gwinn, Marta
    Khoury, Muin J.
    GENOME MEDICINE, 2009, 1
  • [9] A conceptual framework for pharmacodynamic genome-wide association studies in pharmacogenomics
    Wu, Rongling
    Tong, Chunfa
    Wang, Zhong
    Mauger, David
    Tantisira, Kelan
    Szefler, Stanley J.
    Chinchilli, Vernon M.
    Israel, Elliot
    DRUG DISCOVERY TODAY, 2011, 16 (19-20) : 884 - 890
  • [10] Pharmacogenomics discovery and implementation in genome-wide association studies era
    Ni, Xiuqin
    Zhang, Wei
    Huang, R. Stephanie
    WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 2013, 5 (01) : 1 - 9